Log in

Relevant bibliographies by topics / Pharmaceutical technology / Journal articles

Journal articles on the topic 'Pharmaceutical technology'

To see the other types of publications on this topic, follow the link: Pharmaceutical technology.

Author: Grafiati

Published: 4 June 2021

Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Pharmaceutical technology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Pegu, Lukesh, Pankaj Chasta, and Mr Kaushal K. Chandrul. "Pharmaceutical Packaging Technology." International Journal of Trend in Scientific Research and Development Volume-3, Issue-3 (April 30, 2019): 1747–54. http://dx.doi.org/10.31142/ijtsrd23527.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hollenbeck, R. Gary. "Pharmaceutical Technology: Tableting Technology." Journal of Pharmaceutical Sciences 78, no. 2 (February 1989): 182. http://dx.doi.org/10.1002/jps.2600780224.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sharma Meenu, Shivangi. "Pharmaceutical Supply Chain Using Blockchain Technology." International Journal of Science and Research (IJSR) 12, no. 6 (June 5, 2023): 899–902. http://dx.doi.org/10.21275/sr23606113214.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Nasir, Fazli. "Welcome to Pharmaceutical Communications." Pharmaceutical Communications 1, no. 01 (December 31, 2022): 01. http://dx.doi.org/10.55627/pharma.001.001.0203.

Full text

Abstract:

Welcome to the inaugural issue of Pharmaceutical Communications-a biannual, open access, and peer-reviewed journal aiming to publish high-quality research articles in the field of basic & advanced pharmaceutics and pharmaceutical technology. Pharmaceutical Communications is a biannual, peer-reviewed journal published online and in print that primarily publishes research articles and reviews that focus on basic and advanced pharmaceutics. The journal accepts manuscripts related to but not limited to, the processing of pharmaceuticals, such as crystallization, lyophilization, chemical stability of drugs, pharmacokinetics, biopharmaceutics, pro-drug developments, metabolic disposition of bioactive agents, dosage form design, pharmaceutical technology, targeted drug delivery. Other topics include pharmaceutical marketing, pharmaceutical promotion, patient-provider communication, healthcare communication, patient safety, and innovations in the pharmaceutical industry. Pharmaceutical Communications primarily accepts original research articles and reviews. However, invited editorial summaries and letters to the editor are also occasionally published. The journal provides a platform for scientists, practitioners, and healthcare professionals to share their knowledge and experiences in the field of pharmaceutics. The journal also serves as a forum for discussing and debating current issues and trends in the pharmaceutical industry. The journal welcomes submissions from academics, practitioners, and industry professionals who wish to share their research and perspectives on topics related to pharmaceutics. In the last two decades, rapid technological advances have enabled researchers to investigate arcane technological phenomena and ask more profound questions. Several pharmaceutical processes involved in the manufacturing of various dosage forms are being unraveled at a rapid pace, high resolution, and with unprecedented details. Authors carrying out investigations leveraging these technologies dealing with the composition, formulation, preparation, or manufacturing and quality control of extemporaneously compounded or commercially manufactured drugs are encouraged to submit their findings to Pharmaceutical Communications. The purpose of this journal is to provide a platform to the scientific fraternity, especially regional and national academics, where they could get their studies published after a rapid, transparent, and high-quality peer review. All the articles published in Pharmaceutical Communications will be freely available to readers immediately after publication. The open-access policy of our journal is likely to increase the readership of articles and enhance their visibility and citation potential. The journal also welcomes submissions from authors from any country. Therefore, I invite you to submit your work to Pharmaceutical Communications. We look forward to receiving your submissions! Professor Dr. Fazli Nasir Editor-In-Chief Rehabilitation Communications

APA, Harvard, Vancouver, ISO, and other styles

5

Banakar, Umesh V., and W. Wayne Young. "Pharmaceutical Technology Information." Journal of Pharmacy Technology 3, no. 4 (July 1987): 159–61. http://dx.doi.org/10.1177/875512258700300411.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Wu, Chuan-Yu, Abderrahim Michrafy, Aleksander Mendyk, and Satoru Watano. "Pharmaceutical Particle Technology." Powder Technology 285 (November 2015): 1. http://dx.doi.org/10.1016/j.powtec.2015.09.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bodmeier, Roland. "Pharmaceutical Peiletizatlon Technology." Journal of Pharmaceutical Sciences 79, no. 7 (July 1990): 657. http://dx.doi.org/10.1002/jps.2600790727.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Prozherina, Yuliya. "Technology and innovation in the pharmaceutical industry." Remedium. Journal about the Russian market of medicines and medical equipment, no. 1 (2021): 63–64. http://dx.doi.org/10.21518/1561-5936-2021-1-63-64.

Full text

Abstract:

Analytics In recent years, technology and innovation have moved in leaps and bounds, changing all sectors including healthcare and pharmaceutics. The use of Big Data and process automation are driving rapid progress. The most modern approaches are being introduced into pharmacies and pharmaceutical enterprises even today.

APA, Harvard, Vancouver, ISO, and other styles

9

Pilpel, N. "Pharmaceutical technology. Tableting technology vol. 1." Endeavour 12, no. 3 (January 1988): 151. http://dx.doi.org/10.1016/0160-9327(88)90154-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Vasudha, V., and A. R. Laiju. "A Sustainable Approach Towards Wastewater Treatment in Pharmaceutical Industry: A Review." IOP Conference Series: Earth and Environmental Science 1326, no. 1 (June 1, 2024): 012137. http://dx.doi.org/10.1088/1755-1315/1326/1/012137.

Full text

Abstract:

Abstract Effluents from the pharmaceutical industry have become more concerned in recent years due to rising worries about the presence and management of pharmaceutical pollutants, raw materials, intermediates, and solvents. The pharmaceutical industry is one of the largest water consumers due to the many processes that require water. Different drug and pharmaceutical production methods result in wastewater containing a wide range of chemicals such as diclofenac, ibuprofen, carbamazepine, and clorfibric acid are commonly found in water and wastewater. As part of wastewater management, it is essential to analyse and design techniques for treating pharmaceutical wastewater in light of the limited available water resources. Furthermore, the industry mandates the reuse of water after impurities such as pharmaceuticals and other toxins. In our study, the main sources of wastewater in the pharmaceutical sector are identified, and the most effective removal technologies are examined and evaluated with the assistance of the study results. Bulk medications, pharmaceutically active substances, and other pharmaceuticals generate wastewater that utilizes much water. This effluent has been analyzed, and solutions for recovering valuable molecules to a considerable extent have been proposed. Finally, the treatment of wastewater has been addressed. Due to the shortcomings of traditional treatment techniques, the authors modified the conventional treatment procedure here using membrane bioreactors and cutting-edge techniques like ozonation, creating a hybrid wastewater treatment technology that may be a better alternative for treating pharmaceutical wastewater.

APA, Harvard, Vancouver, ISO, and other styles

11

Felton, Linda A. "Pharmaceutical Powder Compaction Technology." Drug Development and Industrial Pharmacy 38, no. 8 (June 29, 2012): 1029. http://dx.doi.org/10.3109/03639045.2012.704045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Siepmann, Juergen, Abdul Basit, and Thomas Rades. "Pharmaceutical Technology in Europe." International Journal of Pharmaceutics 613 (February 2022): 121441. http://dx.doi.org/10.1016/j.ijpharm.2021.121441.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Guzev, K. S. "Galen and Pharmaceutical Technology." Pharmacy & Pharmacology 4, no. 3(16) (January 1, 2016): 84–95. http://dx.doi.org/10.19163/2307-9266-2016-4-3-84-95.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Pilpel, N. "Pharmaceutical technology: Drug stability." Endeavour 13, no. 3 (January 1989): 144. http://dx.doi.org/10.1016/0160-9327(89)90106-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Peck, Garnet E. "Pharmaceutical powder compaction technology." Journal of Controlled Release 42, no. 3 (December 1996): 302. http://dx.doi.org/10.1016/0168-3659(96)83991-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Tyle, Praveen. "Pharmaceutical technology: Drug stability." Journal of Pharmaceutical Sciences 79, no. 4 (April 1990): 372. http://dx.doi.org/10.1002/jps.2600790424.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

DOLENINA, Ol'ga E., and Viktoriya D. PEREVALOVA. "Innovative processes in the German pharmaceutical industry." Economic Analysis: Theory and Practice 22, no. 7 (July 31, 2023): 1384–96. http://dx.doi.org/10.24891/ea.22.7.1384.

Full text

Abstract:

Subject. The article addresses Germany's competitive position in the global pharmaceutical market and R&D development in the pharmaceutical industry. Objectives. The purpose is to provide a unique comprehensive study of innovative processes development in the pharmaceutical industry, using the case of German companies, explore innovative approaches to solving production problems, identify leading German companies in the field of biotechnology, and reveal the most promising areas for the development of German pharmaceuticals. Methods. We employ statistical and cartographic methods, and methods of comparative and economic analysis. Results. In their activities, German pharmaceutical companies combine the production of medicines, medical equipment, innovative developments, and implementation of various treatment, therapy and diagnostic programs. In a highly competitive global generic market, in Germany, there is a trend towards intra-industry structural transformation of pharmaceutical companies. The paper analyzed R&D spending, the geography of research centers of German pharmaceutical companies in the world, and their activities. Conclusions. The specifics of German pharmaceutical industry is the manufacture of high-tech products, using medical biotechnologies, which provides the country's advantage in the world market. Despite the presence of competitors in the generic market, i.e. India and China, German biotechnology-based pharmaceuticals continue to be in high demand among consumers as a high-quality product.

APA, Harvard, Vancouver, ISO, and other styles

18

Khaydarov, V. R., N. S. Fayzullaeva, F. Kh Maksudova, and Sh B. Yusupova. "OPTIMIZATION OF THE TECHNOLOGY OF “PHOSFARGININE SUCCINATE” INFUSION SOLUTION." American Journal of Applied Sciences 04, no. 11 (November 1, 2022): 09–23. http://dx.doi.org/10.37547/tajas/volume04issue11-02.

Full text

Abstract:

In recent years, much attention has been paid to providing the population with domestically produced pharmaceuticals, the production of new import-substituting drugs that are affordable from an economic point of view, important tasks have been identified for “the development of the pharmaceutical industry, as well as improving the provision of the population and medical institutions with cheap, high-quality drugs”. In this regard, the search for new drugs, their introduction into the pharmaceutical industry is being carried out. One of these drugs is "Phosfarginine succinate" (consisting of D-fructose-1,6-diphosphate trisodium salt, L-arginine hydrochloride, succinic acid) infusion solution - a drug that stimulates and regulates the metabolic process. The infusion solution technology was developed on the basis of Temur Med Farm LLC (Republic of Uzbekistan). In order to select a scientifically based composition, develop and optimize the technological process, the method of mathematical planning of the experiment was used - Latin plans. The application of the method of mathematical planning of the experiment made it possible to select the optimal composition and technology of the infusion solution “Phosfarginine succinate”.

APA, Harvard, Vancouver, ISO, and other styles

19

Cheng, Zhongyao, Yumei Lian, Zul Kamal, Xin Ma, Jianjun Chen, Xinbo Zhou, Jing Su, and Mingfeng Qiu. "Nanocrystals Technology for Pharmaceutical Science." Current Pharmaceutical Design 24, no. 21 (October 15, 2018): 2497–507. http://dx.doi.org/10.2174/1381612824666180518082420.

Full text

Abstract:

Background: Nanocrystals technology is a promising method for improving the dissolution rate and enhancing the bioavailability of poorly soluble drugs. In recent years, it has been developing rapidly and applied to drug research and engineering. Nanocrystal drugs can be formulated into various dosage forms. Objective: This review mainly focused on the nanocrystals technology and its application in pharmaceutical science. Firstly, different preparation methods of nanocrystal technology and the characterization of nanocrystal drugs are briefly described. Secondly, the application of nanocrystals technology in pharmaceutical science is mainly discussed followed by the introduction of sustained release formulations. Then, the scaling up process, marketed nanocrystal drug products and regulatory aspects about nanodrugs are summarized. Finally, the specific challenges and opportunities of nanocrystals technology for pharmaceutical science are summarized and discussed. Conclusion: This review will provide a comprehensive guide for scientists and engineers in the field of pharmaceutical science and biochemical engineering.

APA, Harvard, Vancouver, ISO, and other styles

20

Wesolowski, M. "Thermoanalytical methods in pharmaceutical technology." Journal of Thermal Analysis 38, no. 9 (September 1992): 2239–45. http://dx.doi.org/10.1007/bf01979638.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

West, Donna S., and Sheryl Szeinbach. "Information Technology and Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 37, no. 5 (September 1997): 497–501. http://dx.doi.org/10.1016/s1086-5802(16)30252-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Peppas, N. A. "Controlled-release technology: Pharmaceutical applications." Journal of Controlled Release 7, no. 2 (July 1988): 186. http://dx.doi.org/10.1016/0168-3659(88)90014-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Brannon, M. Lisa. "Controlled release technology: Pharmaceutical applications." Journal of Controlled Release 7, no. 3 (September 1988): 289. http://dx.doi.org/10.1016/0168-3659(88)90068-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Zustiak, Silviya Petrova, and Era Jain. "Feature Reviews in Pharmaceutical Technology." Pharmaceuticals 16, no. 10 (September 22, 2023): 1336. http://dx.doi.org/10.3390/ph16101336.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Samanthula, Kumara Swamy, Durgaprasad Kemisetti, Jithendar Reddy Mandhadi, Chandrashekar Thalluri, and Biplab Kumar Dey. "Novel Applications of Hot Melt Extrusion Technology." Journal of Drug Delivery and Therapeutics 13, no. 4 (April 15, 2023): 154–58. http://dx.doi.org/10.22270/jddt.v13i4.5794.

Full text

Abstract:

Hot melt extrusion (HME) technology was introduced to pharmaceuticals in the 1970s for manufacturing and product development. Since then, there were several developments in HME technology to utilize it effectively for the manufacturing of pharmaceuticals. Though the primary purpose of HME technology remains to be solubility enhancement through the preparation of amorphous solid dispersions, it also has various other applications like dry granulation, abuse-deterrent formulation, continuous manufacturing, film preparation, implants, sustained release formulations, etc. The purpose of this review article is to consolidate the information related to applications of HME technology in the pharmaceutical industry. Keywords: Hot melt extrusion, poorly soluble drugs, continuous manufacturing, solid orals, and applications.

APA, Harvard, Vancouver, ISO, and other styles

26

Laca Megyesi, S., A. Königová, L. Molnár, M. Várady, M. Fedorová, and J. Eftimová. "Drug Technology in Hunting Practice." European Pharmaceutical Journal 68, no. 1 (January 1, 2021): 63–65. http://dx.doi.org/10.2478/afpuc-2021-0004.

Full text

Abstract:

Abstract Antiparasitic therapy in living ratites is based on the right dose and efficacy is only when the drug is pharmaceutically stable and safe. Ivermectin is considered to be the most widely used drug in the treatment of parasitosis in ruminants worlwide. For these reasons, in our study, we focused on the pharmaceutical investigation of ivermectin by SEM analysis of its powder particle shape and size, flow properties of solids (angle of repose, compressibility index, Hausner ratio) and zeta potential.

APA, Harvard, Vancouver, ISO, and other styles

27

Ren, Nai Fei, Xiu Jie Wang, and Yang Li. "Development of Pharmaceutical Production Management System Based on RFID." Key Engineering Materials 522 (August 2012): 810–13. http://dx.doi.org/10.4028/www.scientific.net/kem.522.810.

Full text

Abstract:

Pharmaceutical is related to people's health and life safety directly, we can track and control pharmaceutical safety and quality by constructing the traceable system of pharmaceuticals whole life cycle, including raw materials, production, transportation and storage. This paper develops a pharmaceutical production management system based on RFID technology, the system realizes the drug security by RFID, puts forward a pharmaceutical coding method according to EPCgloble, constructs a scheduling method and a monitoring of the pharmaceutical production process, and then it will be traceable for the information of pharmaceutical production process.

APA, Harvard, Vancouver, ISO, and other styles

28

Sabliy, L. Sabliy. "EFFECTIVE TECHNOLOGY OF PHARMACEUTICAL ENTERPRISES WASTEWATER LOCAL TREATMENT FROM ANTIBIOTICS." Biotechnologia Acta 13, no. 3 (June 2020): 81–88. http://dx.doi.org/10.15407/biotech13.03.081.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Ravindran, K., J. Pranav Niranjan, and A. Sam Osborn. "A Secure System for Buying and Verifying the Authenticity of Drugs Using Blockchain Technology." Asian Journal of Science and Applied Technology 12, no. 2 (December 5, 2023): 32–38. http://dx.doi.org/10.51983/ajsat-2023.12.2.4047.

Full text

Abstract:

In the healthcare sector, ensuring the safety and legitimacy of drugs is a top priority. Counterfeit pharmaceuticals are a major problem for the industry, as they not only cause financial losses but also endanger public health and safety. These fake medications are hazardous or inefficient, putting lives at risk. The dissemination of fake medications has not been stopped by the use of conventional techniques for confirming drug legitimacy. This project presents a novel way to improve the security and authenticity of pharmaceutical purchases by utilizing blockchain technology. The key focus of this innovative project is to devise a blockchain-based secure system that will enable drug producers, distributors, and consumers to safely check the legitimacy of pharmaceuticals and track their provenance throughout the supply chain. The utilization of decentralized and immutable properties of blockchain technology makes it possible to create a transparent and impenetrable platform for documenting and confirming drug-related transactions. The blockchain will securely store every stage of the pharmaceutical supply chain, from production to retail, establishing a transparently traceable framework. Implementing a secure blockchain-based system for drug authentication helps effectively build trust within the pharmaceutical supply chain, protect consumers from counterfeit drugs, and make a positive impact on the overall improvement of public health. The transparency and security offered by blockchain technology in drug transactions have the potential to revolutionize the pharmaceutical industry, fostering a more reliable environment for drug procurement and distribution.

APA, Harvard, Vancouver, ISO, and other styles

30

Haryanto, Luthfi Izzatul Azka, and Ridho Firdaus. "Blockchain Technology based Smart Contract Model in Indonesia." Blockchain Frontier Technology 2, no. 2 (November 8, 2022): 59–63. http://dx.doi.org/10.34306/bfront.v2i2.211.

Full text

Abstract:

The primary task of integrated product supply chain management is distribution. The processing, storage, and distribution of high-quality pharmaceutical products makes the drug distribution process crucial in the pharmaceutical sector. The distribution of fake medications by associated parties, such as unauthorized or unregistered distributors or data collecting for unregistered medications distributed by distributors, is a concern in the pharmaceutical industry. Drug production permits that are misused up until they are distributed or circulated do not adhere to the Food and Drug Supervisory Agencies standard requirements. In order to facilitate the distribution process by recording data distribution, providing data security, and giving traceability of transactions between linked parties, these issues must be rapidly resolved with technology help. By utilizing blockchain technology, this study suggests a beneficial medicine delivery approach. A user-centered design and a qualitative methodology are used in the model creation. This study's output is a blockchain-based drug delivery mechanism that has been verified. Transparency, security, traceability, decentralization, automation, immutability, and reliability are all features of the model. By ensuring that the pharmaceuticals supplied are of high quality, this strategy can assist the government in promoting community safety, health, and trust in the drugs that are in use.

APA, Harvard, Vancouver, ISO, and other styles

31

Wu, Huiquan, and Mansoor Khan. "THz spectroscopy: An emerging technology for pharmaceutical development and pharmaceutical Process Analytical Technology (PAT) applications." Journal of Molecular Structure 1020 (August 2012): 112–20. http://dx.doi.org/10.1016/j.molstruc.2012.04.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Schubert, Francois. "HEALTH TECHNOLOGY ASSESSMENT." International Journal of Technology Assessment in Health Care 18, no. 2 (April 2002): 184–91. http://dx.doi.org/10.1017/s0266462302000193.

Full text

Abstract:

Increasingly, health technology assessment (HTA) is used to aid decisions on the reimbursement of pharmaceuticals or recommendations for their use. The pharmaceutical industry seeks to work in partnership with HTA agencies; however, this presents a number of challenges. Clinical trials will need to include appropriate measures that capture economic and patient benefits as well as relevant clinical endpoints, and the industry will want to seek international harmonization of the many guidelines for economic evaluation. The problem of demonstrating cost-effectiveness of a product before it is available for use must be addressed, possibly by conditional reimbursement to allow collection of real world evidence. It is also important that reimbursement decision makers minimize bias, play fair, and adhere to the written rules they issue. If the industry fairly demonstrates the value of a product using the best available evidence, HTA agencies should be transparent in the rationale for their recommendations.

APA, Harvard, Vancouver, ISO, and other styles

33

Ianno, Veronica, Sarah Vurpillot, Sylvain Prillieux, and Philippe Espeau. "Pediatric Formulations Developed by Extrusion-Based 3D Printing: From Past Discoveries to Future Prospects." Pharmaceutics 16, no. 4 (March 22, 2024): 441. http://dx.doi.org/10.3390/pharmaceutics16040441.

Full text

Abstract:

Three-dimensional printing (3DP) technology in pharmaceutical areas is leading to a significant change in controlled drug delivery and pharmaceutical product development. Pharmaceutical industries and academics are becoming increasingly interested in this innovative technology due to its inherent inexpensiveness and rapid prototyping. The 3DP process could be established in the pharmaceutical industry to replace conventional large-scale manufacturing processes, particularly useful for personalizing pediatric drugs. For instance, shape, size, dosage, drug release and multi-drug combinations can be tailored according to the patient’s needs. Pediatric drug development has a significant global impact due to the growing needs for accessible age-appropriate pediatric medicines and for acceptable drug products to ensure adherence to the prescribed treatment. Three-dimensional printing offers several significant advantages for clinical pharmaceutical drug development, such as the ability to personalize medicines, speed up drug manufacturing timelines and provide on-demand drugs in hospitals and pharmacies. The aim of this article is to highlight the benefits of extrusion-based 3D printing technology. The future potential of 3DP in pharmaceuticals has been widely shown in the last few years. This article summarizes the discoveries about pediatric pharmaceutical formulations which have been developed with extrusion-based technologies.

APA, Harvard, Vancouver, ISO, and other styles

34

Nilsson, F., M. Ekblad, J. la Cour Jansen, and K. Jönsson. "Removal of pharmaceuticals with ozone at 10 Swedish wastewater treatment plants." Water Practice and Technology 12, no. 4 (December 1, 2017): 871–81. http://dx.doi.org/10.2166/wpt.2017.087.

Full text

Abstract:

Abstract Pilot-scale tests were run with ozonation for reduction of 24 pharmaceuticals at 10 full-scale wastewater treatment plants in southern Sweden. Reduction was evaluated based on doses of 3, 5 and 7 g O3/m3 at all plants. The reduction of pharmaceuticals reached on average 65% at 3 g O3/m3, 78% at 5 g O3/m3 and 88% for 7 g O3/m3 in terms of total concentration of pharmaceuticals. Specific ozone dose (ratio O3:TOC) was found to be highly influential on pharmaceutical removal. At two WWTPs, the pharmaceutical removal was severely reduced.

APA, Harvard, Vancouver, ISO, and other styles

35

Erokhin, Aleksandr, Konstantin Koshechkin, and Ilya Ryabkov. "The distributed ledger technology as a measure to minimize risks of poor-quality pharmaceuticals circulation." PeerJ Computer Science 6 (September 14, 2020): e292. http://dx.doi.org/10.7717/peerj-cs.292.

Full text

Abstract:

Background In the modern world, millions of people suffer from fake and poor-quality medical products entering the market. Violation of the rules of transportation of drugs makes them ineffective and even dangerous. The relationship between the various parts of the supply chain, production and regulation of drugs is too hard and has many problems. Distributed ledger technology is a distributed database, the properties of which allow us to track the entire path of medical products from the manufacturer to consumer, to improve the current model of the supply chain, to transform the pharmaceutical industry and prevent falsified drugs reach the market. Objective The aim of the article is to analyze the distributed ledger technology as an innovative means of poor-quality pharmaceuticals prevention to reach the market as well as their forehanded detection. Methods Content analysis of web sites of companies developing distributed ledger technology solutions had been performed. Five examples found with a google search engine by keywords “distributed ledger technology”, “blockchain”, “pharmaceuticals” and “supply chain” were examined. Analysis of relative scientific publications had been made. With the help of generalization and systematization methods, services provided by these companies were analyzed. The visual model of the supply chain was created with Microsoft Visio software. Results The analysis results contain a principle scheme of distributed ledger technology implementation to achieve the objectives. The analysis of present-day pharmaceuticals supply chain structure and the distributed ledger technology capacities to improve pharmaceutical companies has been carried out and presented. Furthermore, the article allows getting acquainted with today’s projects released to the market as well as the prognosis of the distributed ledger technology in pharmaceutical industry enhancement in the future.

APA, Harvard, Vancouver, ISO, and other styles

36

Pardeshi, Sagar R., Eknath B. Kole, Harshad S. Kapare, Sachin M. Chandankar, Prashant J. Shinde, Ganesh S. Boisa, Sanjana S. Salgaonkar, et al. "Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations." Pharmaceutics 14, no. 12 (November 28, 2022): 2632. http://dx.doi.org/10.3390/pharmaceutics14122632.

Full text

Abstract:

The surface drying process is an important technology in the pharmaceutical, biomedical, and food industries. The final stage of formulation development (i.e., the drying process) faces several challenges, and overall mastering depends on the end step. The advent of new emerging technologies paved the way for commercialization. Thin film freezing (TFF) is a new emerging freeze-drying technique available for various treatment modalities in drug delivery. TFF has now been used for the commercialization of pharmaceuticals, food, and biopharmaceutical products. The present review highlights the fundamentals of TFF along with modulated techniques used for drying pharmaceuticals and biopharmaceuticals. Furthermore, we have covered various therapeutic applications of TFF technology in the development of nanoformulations, dry powder for inhalations and vaccines. TFF holds promise in delivering therapeutics for lung diseases such as fungal infection, bacterial infection, lung dysfunction, and pneumonia.

APA, Harvard, Vancouver, ISO, and other styles

37

Wedha, Bayu Yas, Michael Sagar Vasandani, and Alessandro Enriqco Putra Bayu Wedha. "Innovative Role of Blockchain Pharmaceutical Supply Chain Digital Transformation: Enterprise Architecture Perspective." sinkron 8, no. 4 (October 1, 2023): 2490–500. http://dx.doi.org/10.33395/sinkron.v8i4.13043.

Full text

Abstract:

The advent of the Fourth Industrial Revolution has compelled numerous industries to undergo digital changes or transformations. One example is the pharmaceutical industry, which is responsible for providing medicinal products. The pharmaceutical supply chain assumes a crucial position within the pharmaceutical industry as it enables the secure, streamlined, and dependable transportation of medications from producers to individuals in need. The issue of prioritizing digital transformation within the pharmaceutical supply chain has emerged as a significant problem for hospitals and pharmaceutical businesses. Integrating different components inside the system is effectively supported by the substantial function fulfilled by Enterprise Architecture in this specific context. The objective is to minimize errors, enhance inventory management, optimize product distribution, and guarantee the safety and quality of pharmaceuticals. However, the process of adequately monitoring and verifying data has its challenges. However, these challenges can be efficiently addressed through implementing blockchain technology. In addition to this, Blockchain technology has the potential to enhance industrial efficiency. Utilizing blockchain technology enables the facilitation of transparency, immutability, and data integrity across the entirety of the supply chain. Integrating Enterprise Architecture electronic automation with Blockchain technology enables pharmaceutical enterprises to establish robust systems facilitated by Smart Contracts. The use of this system is expected to significantly enhance automation and regulatory adherence within supply chain processes, leading to notable advancements in operational efficiency, security, and data accuracy. Integrating blockchain technology and smart contracts enables pharmaceutical enterprises to enhance their product offers to hospitals and patients at reduced expenses, facilitating notable advancements in Enterprise Architecture.

APA, Harvard, Vancouver, ISO, and other styles

38

Akers, Michael J. "Pharmaceutical Development and Technology (PDT) announcements." Pharmaceutical Development and Technology 17, no. 2 (February 15, 2012): 129–30. http://dx.doi.org/10.3109/10837450.2012.660308.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Swarbrick, James, and James J. Boylan. "Book Review: Encyplopedia of Pharmaceutical Technology." Reaction Kinetics and Catalysis Letters 81, no. 2 (2004): 399–400. http://dx.doi.org/10.1023/b:reac.0000019449.29628.46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Leung, Musetta Y., Michael T. Halpern, and Nathan D. West. "Pharmaceutical Technology Assessment: Perspectives from Payers." Journal of Managed Care Pharmacy 18, no. 3 (April 2012): 256–65. http://dx.doi.org/10.18553/jmcp.2012.18.3.256.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Duchěne, D., C. Vaution, and F. Glomot. "Cyclodextrins, Their Value in Pharmaceutical Technology." Drug Development and Industrial Pharmacy 12, no. 11-13 (January 1986): 2193–215. http://dx.doi.org/10.3109/03639048609042630.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Bernstein, James S. "Applications of NMR to Pharmaceutical Technology." Applied Spectroscopy Reviews 30, no. 1-2 (February 1995): 119–37. http://dx.doi.org/10.1080/05704929508003312.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Doyle, Brendon J., Petteri Elsner, Bernhard Gutmann, Olivier Hannaerts, Christof Aellig, Arturo Macchi, and Dominique M. Roberge. "Mini-Monoplant Technology for Pharmaceutical Manufacturing." Organic Process Research & Development 24, no. 10 (August 26, 2020): 2169–82. http://dx.doi.org/10.1021/acs.oprd.0c00207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Lagarce, Frederic. "Pharmaceutical Technology to Improve Patient Care." Pharmaceutical Technology in Hospital Pharmacy 3, no. 4 (November 27, 2018): 189–90. http://dx.doi.org/10.1515/pthp-2018-0032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Das, Pratik Swarup, Puja Saha, Krishan, and Rumpa Das. "Pharmaceutical Packaging Technology: A Brief Outline." Research Journal of Pharmaceutical Dosage Forms and Technology 10, no. 1 (2018): 23. http://dx.doi.org/10.5958/0975-4377.2018.00005.8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Puthli, Shivanand P. "Pharmaceutical technology management – profitable business avenue." Expert Opinion on Drug Delivery 7, no. 1 (December 18, 2009): 1–5. http://dx.doi.org/10.1517/17425240903479925.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Felkey, Bill G., and Kenneth N. Barker. "Technology and Automation in Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 36, no. 5 (May 1996): 309–14. http://dx.doi.org/10.1016/s1086-5802(16)30062-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Jakke Vyshnavi, Yerikala Ramesh, P Venugopalaiah, and Y Prapurna Chandra. "3D printing technology in pharmaceutical science." International Journal of Pharmacometrics and Integrated Biosciences 8, no. 4 (November 27, 2023): 5–17. http://dx.doi.org/10.26452/ijpib.v8i4.1504.

Full text

Abstract:

Multi printers (3dp) are indeed an innovative tech that permits its fakery like custom-fit substances, equipment, but also body parts a certain conference a private patient’s prerequisite. Thus, this has tremendous potential complete bring on a major conversion inside the pharm as well as health care. 3D printing technology encompasses this same producer-like formation of wanted to create whilst also condensation-like printers’ stuff in a layer-by-layer dress. This enables on-demand manufacturing-like systems with high performance. Nowadays, it's employed in several health care including profiling, implantable implants, morphological brands, synthetic biology as well as cell therapy, and orchestrated cell brands, but instead dental care. The first unbiased of all this summary is to explain different methods of precision medicine, advancement along delivery systems but also systems, 3D printing technology methodologies, use of polymer matrix through 3D printing technology, but instead adjustment yeah 3D printing technology throughout drug makers. Researchers additionally define recent versions there in falsification like repeated tasks profiling as well as based drug delivery processes as well as make a comparison a 3D printer as for biomaterials. Last but, researchers discuss the challenges, regulations elements, as well as emerging outcomes after all 3Dprinter’s Technology in Medical Configuration.Top of Form

APA, Harvard, Vancouver, ISO, and other styles

49

Kasi, Sudheer Kumar. "Pharmaceutical Drug Serialization in the Supply Chain." International Journal for Research in Applied Science and Engineering Technology 11, no. 8 (August 31, 2023): 99–103. http://dx.doi.org/10.22214/ijraset.2023.55130.

Full text

Abstract:

Abstract: Pharmaceutical medication serialization is often a regulatory requirement established by large nations to combat pharmaceutical drug counterfeiting. Since the 19th century, drug fraud has been a serious issue for the healthcare sector. The regulator y and healthcare organizations struggle from time to time to reduce the danger of negative outcomes brought on by fake medications. According to estimates from the World Health Organization (WHO), four out of every ten pharmaceuticals sold in underdeveloped or disadvantaged nations may be tainted. Ultimately, because of stolen, diverted, and counterfeit pharmaceuticals, drug makers lose billions of dollars annually. The regulatory authorities are currently developing severe regulations to prevent criminals from supplying and diverting fake or stolen medicine in the supply chain. To offer patients with safe and authentic medications, the healthcare business needs strict rules and secure traceability technologies. In essence, pharmaceutical drug serialization offers benefits by enhancing the supply chain's drug security by lowering adverse occurrences and investigations. Additionally, tracking and tracing technology is used in pharmaceutical drug serialization to take advantage of the advantages of tracking individual drug packages in the supply chain.

APA, Harvard, Vancouver, ISO, and other styles

50

Manipriyanka K and Ravi Kishore Naidu. "Advances in Drug Formulation Technology: Enhancing Bioavailability and Patient Compliance." Journal of Advanced Zoology 44, S-5 (November 10, 2023): 2125–30. http://dx.doi.org/10.17762/jaz.v44is-5.1719.

Full text

Abstract:

Drug formulation technology is continuously evolving to improve the efficacy and patient experience of pharmaceuticals. This paper explores recent advancements in drug formulation techniques aimed at enhancing drug bioavailability and promoting patient compliance. By addressing challenges related to drug solubility, stability, and delivery, these innovations have the potential to revolutionize drug development and patient care. This paper provides an overview of these advancements, their mechanisms, and their impact on the pharmaceutical industry and healthcare.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!